We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FRO:NYSEFrontline Plc Analysis

Data as of 2026-06-18 - not real-time

$38.85

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Frontline plc (FRO) is trading at $38.85, comfortably above its 20‑day SMA ($36.53) and 50‑day SMA ($36.50) while still below the 200‑day SMA ($29.05) trend line, indicating a bullish momentum that is reinforced by a MACD histogram of +0.46 and an RSI of 62, well under the overbought threshold. The stock enjoys a low beta of 0.44 and a 30‑day volatility of 36.9%, suggesting modest market sensitivity but notable price swings. Fundamentally, the company posted a remarkable 66.9% revenue growth, robust gross (55.8%) and operating (51.8%) margins, and a net profit margin of 40.2%, all of which underpin a forward‑looking DCF fair value of $51.36 – roughly a 7.5% upside from current levels. Recent news highlights a 50% dividend increase and record quarterly adjusted profit, further bolstering confidence in earnings sustainability.
Given the extreme greed sentiment (Fear & Greed Index 88.5) and a solid support at $33.80 versus resistance near $40.17, the technical setup aligns with the undervalued valuation grade, making FRO an attractive candidate for investors seeking both growth and value exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (MACD, RSI, price above short‑term SMAs)
  • Strong quarterly earnings and margin expansion
  • Support level provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained revenue growth of 66.9% and high profitability
  • DCF valuation indicates ~7% upside
  • Favorable tanker market dynamics post‑Strait of Hormuz events

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Large, modern fleet positioning for future demand cycles
  • High leverage balanced by strong operating cash flow
  • Industry cyclicality mitigated by diversified vessel mix

Key Metrics & Analysis

Financial Health

Revenue Growth66.90%
Profit Margin40.19%
P/E Ratio9.6
ROE35.01%
ROA9.21%
Debt/Equity92.62
P/B Ratio3.0
Op. Cash Flow$927.0M
Free Cash Flow$374.0M
Industry P/E20.4

Technical Analysis

TrendBullish
RSI62.1
Support$33.80
Resistance$40.17
MA 20$36.53
MA 50$36.50
MA 200$29.05
MACDBullish
VolumeStable
Fear & Greed Index88.5

Valuation

Fair Value$51.36
Target Price$41.75
Upside/Downside7.46%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.44
Volatility36.87%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.